O'Hagan S - Search Results

1

Deorphanizing solute carriers in Saccharomyces cerevisiae for secondary uptake of xenobiotic compounds.

Møller-Hansen I, Sáez-Sáez J, van der Hoek SA, Dyekjær JD, Christensen HB, Wright Muelas M, O'Hagan S, Kell DB, Borodina I. Møller-Hansen I, et al. Among authors: o hagan s. Front Microbiol. 2024 Apr 12;15:1376653. doi: 10.3389/fmicb.2024.1376653. eCollection 2024. Front Microbiol. 2024. PMID: 38680917 Free PMC article.

2

Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites.

O'Hagan S, Kell DB. O'Hagan S, et al. Front Pharmacol. 2015 May 13;6:105. doi: 10.3389/fphar.2015.00105. eCollection 2015. Front Pharmacol. 2015. PMID: 26029108 Free PMC article.

3

Generation of a Small Library of Natural Products Designed to Cover Chemical Space Inexpensively.

O'Hagan S, Kell DB. O'Hagan S, et al. Pharm Front. 2019;1(1):e190005. doi: 10.20900/pf20190005. Epub 2019 Aug 9. Pharm Front. 2019. PMID: 31485581 Free PMC article.

4

An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines.

Wright Muelas M, Roberts I, Mughal F, O'Hagan S, Day PJ, Kell DB. Wright Muelas M, et al. Metabolomics. 2020 Oct 7;16(10):107. doi: 10.1007/s11306-020-01725-8. Metabolomics. 2020. PMID: 33026554 Free PMC article.

5

O'Hagan S, Kell DB. O'Hagan S, et al. Mar Drugs. 2020 Nov 23;18(11):582. doi: 10.3390/md18110582. Mar Drugs. 2020. PMID: 33238416 Free PMC article.

6

A palette of fluorophores that are differentially accumulated by wild-type and mutant strains of Escherichia coli: surrogate ligands for profiling bacterial membrane transporters.

Salcedo-Sora JE, Jindal S, O'Hagan S, Kell DB. Salcedo-Sora JE, et al. Microbiology (Reading). 2021 Feb;167(2):001016. doi: 10.1099/mic.0.001016. Microbiology (Reading). 2021. PMID: 33406033 Free PMC article.

7

MetMaxStruct: A Tversky-Similarity-Based Strategy for Analysing the (Sub)Structural Similarities of Drugs and Endogenous Metabolites.

O'Hagan S, Kell DB. O'Hagan S, et al. Front Pharmacol. 2016 Aug 22;7:266. doi: 10.3389/fphar.2016.00266. eCollection 2016. Front Pharmacol. 2016. PMID: 27597830 Free PMC article.

8

Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.

Grixti JM, O'Hagan S, Day PJ, Kell DB. Grixti JM, et al. Front Pharmacol. 2017 Mar 27;8:155. doi: 10.3389/fphar.2017.00155. eCollection 2017. Front Pharmacol. 2017. PMID: 28396636 Free PMC article.

9

The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data.

Wright Muelas M, Mughal F, O'Hagan S, Day PJ, Kell DB. Wright Muelas M, et al. Sci Rep. 2019 Nov 29;9(1):17960. doi: 10.1038/s41598-019-54288-7. Sci Rep. 2019. PMID: 31784565 Free PMC article.

10

Exploiting genomic knowledge in optimising molecular breeding programmes: algorithms from evolutionary computing.

O'Hagan S, Knowles J, Kell DB. O'Hagan S, et al. PLoS One. 2012;7(11):e48862. doi: 10.1371/journal.pone.0048862. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185279 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters